Member Info for maximillion69

Https://x.com/maxkrucoff_md/status/1849130344726868300?s=46

Https://www.linkedin.com/posts/hyamtec_have-you-registered-for-the-aea-annual-conference-activity-7254531276508905473-Zrxx?utm_source=share&utm_medium=member_ios

Semantic

I appreciate your views and correspondence albeit I may not fully comprehend . It would be very good of you if you could advise the BB if you are or not invested here . Sorry if you have previously and I’ve missed .

Thanks

I’m not too sure the IB team are overly pleased ,as suggested , with the shenanigans , reading into some correspondence .

TB and crew have totally taken advantage of holders making the most of time issues .

Can you buy some more please

machin

Thanks for sharing Gee

Good luck

Max

Hi semantic. Can you pleases give share holders your positive interpretation now .

I think have a read of the Iqai board you’ll soon grasp what TBs intentions are

It was stated in RNS approx phase 2 costs. 2 to 21/2 mill on going. with IQ contributing

TB cheap share show will continue

Let’s hope phase 1 results are good

Do we not need a raise for phase 2

Can’t see TB paying more than 1.5 for shares

If Trev is moving shares ,could the rounded buys just be him topping the pot up to the brim .

Https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11283430/

Tyke

I posed the question and had an answer ,

This is an administrative designation and does not interfere with our ownership

Https://www.linkedin.com/posts/blackford-analysis-ltd_radiology-healthcareinnovation-medicalimaging-activity-7249778447714070529-hrD4?utm_source=share&utm_medium=member_ios

A response from the PRV at the FDA

Thank you for your inquiry.

The rare pediatric disease priority review voucher (RPD PRV) program will begin to sunset after September 30, 2024. FDA may not issue a RPD PRV after September 30, 2024, unless the drug was designated as a drug for a rare pediatric disease before this date and is approved no later than September 30, 2026 ( Rare Pediatric Disease Designation and Priority Review Voucher Programs | FDA)

Priority Review Vouchers

Office of Program Operations

Office of New Drugs

I asked if it was possible for a drug to get approval in that time their response was “yes it Is “

Hope yet !

It would show there’s quite a demand for IB tech would you say ?

Https://www.uantwerpen.be/en/projects/iq-brain/

Interesting , although I can’t see any connection other than than GE Healthcare

Last update on IB Zero wast annual report April no doubt collecting data takes time

I would think Ph2 and Expanded Access would of been priority

Https://x.com/iqai_ib/status/1842278938111774853?s=46

Not sure why IB haven’t tweeted the video themselves hopefully to busy ! Or maybe TB deciding to get if his A##e